Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maiguan Fukang
- Development stage
- Unknown
- Lead developer
- Xiyuan Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Maiguan Fukang is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of vascular diseases associated with blood stasis and meridian obstruction. It is composed of a complex mixture of herbal extracts, including *Salvia miltiorrhiza* (Danshen), *Pueraria lobata* (Gegen), and *Carthamus tinctorius* (Honghua). The drug is indicated for conditions such as thromboangiitis obliterans, arteriosclerosis obliterans, and carotid artery stenosis. Maiguan Fukang is believed to promote blood circulation, inhibit platelet aggregation, and improve vascular endothelial function. It is currently being evaluated in a Phase 4 clinical trial in China to assess its efficacy in reducing carotid intima-media thickness and stabilizing plaques in patients with mild to moderate carotid stenosis.
- Brand names
- Maiguan FukangBuchang Maiguan Fukang
- Other names
- Maiguan Fukang TabletsMaiguan Fukang Pian脉管复康片Maiguan Fukang CapsulesMaiguan Fukang Jiaonang脉管复康胶囊
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)
Beyond the preview
Go deeper on Maiguan Fukang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maiguan Fukang.